FindTrial
Sign In

Relationship between autologous stem cell transplantation combined with core decompression for early idiopathic avascular necrosis of femoral head and the activity of autologous stem cells

Efficacy and mechanism of tissue engineered autologous stem cell transplantation combined with core decompression for early avascular necrosis of the femoral head

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-17011698
Enrollment
Unknown
Registered
2017-06-19
Start date
2016-06-01
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular necrosis of the femoral head

Interventions

Case series:autologous stem cell transplantation combined with core decompression

Sponsors

The Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with early idiopathic avascular necrosis of the femoral head

Exclusion criteria

Exclusion criteria: 1. Other types of avascular necrosis of the femoral head; 2. Required the application of hormone or immunosuppressant; 3. After hip surgery; 4. Diabetes, hyperthyroidism and other metabolic diseases; 5. Infection; 6. Combined immunodeficiency disease; 7. Tumor; 8. Very few high expectations, or not practical for patients.

Design outcomes

Primary

MeasureTime frame
cell viability of bone marrow mesenchymal stem cells;Differentiating ability of mesenchymal stem cells;Harris score of hip joint before and after operation;The area of necrosis of femoral head before and after operation;—

Countries

China

Contacts

Public ContactChuan Ye

The Affiliated Hospital of Guizhou Medical University

545255355@qq.com+86 13984822777

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 28, 2026